Treatment of minor ischemic stroke with intravenous thrombolysis

Takeaway

  • It is possible that magnetic resonance imaging (MRI) targets – rather than symptom severity – could be used to better triage patients with minor acute ischemic stroke (mAIS) for intravenous tissue plasminogen activator (IV tPA) therapy. Randomized trials are needed to investigate this further.

Why this matters

  • People with mild symptoms of ischemic stroke are at risk of neurological deterioration and disability. It remains unclear whether mAIS patients without clearly disabling symptoms could also benefit from IV tPA therapy.

  • An increase in rapid magnetic resonance imaging (MRI) screening of patients with suspected mAIS has led to the observation that the presence of MRI targets is independent from symptom severity and could be a useful tool for targeted IV tPA treatment.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.